Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Blanke

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Clinical Colorectal Cancer|August 24, 2011
Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysisDaniel J Renouf, Howard J Lim, Caroline Speers, et al.
JAMA Network Open|August 10, 2019
Trends in Medical Aid in Dying in Oregon and WashingtonLuai Al Rabadi, Michael LeBlanc, Taylor Bucy, et al.
Journal of Surgical Oncology|June 26, 2024
Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson, et al.
Clinical Colorectal Cancer|December 17, 2005
Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Clinical Colorectal Cancer|June 8, 2007
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Cancer|September 24, 2020
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine reportMonica M Bertagnolli, Charles D Blanke, Walter J Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer PreventionHoward H Bailey, Linus T Chuang, Nefertiti C duPont, et al.
Journal of Oncology Practice|January 11, 2019
Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative MedicineLaura Tenner, Fay J Hlubocky, Charles D Blanke, et al.
The Oncologist|July 9, 2011
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practiceCharles D Blanke, Richard M Goldberg, Axel Grothey, et al.
Journal of the National Cancer Institute|December 14, 2018
Current Activities of the Coalition of Cancer Cooperative GroupsMonica M Bertagnolli, Susan M Blaney, Charles D Blanke, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Clinical Colorectal Cancer|August 24, 2011
Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysisDaniel J Renouf, Howard J Lim, Caroline Speers, et al.
JAMA Network Open|August 10, 2019
Trends in Medical Aid in Dying in Oregon and WashingtonLuai Al Rabadi, Michael LeBlanc, Taylor Bucy, et al.
Journal of Surgical Oncology|June 26, 2024
Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson, et al.
Clinical Colorectal Cancer|December 17, 2005
Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Clinical Colorectal Cancer|June 8, 2007
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Cancer|September 24, 2020
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine reportMonica M Bertagnolli, Charles D Blanke, Walter J Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer PreventionHoward H Bailey, Linus T Chuang, Nefertiti C duPont, et al.
Journal of Oncology Practice|January 11, 2019
Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative MedicineLaura Tenner, Fay J Hlubocky, Charles D Blanke, et al.
The Oncologist|July 9, 2011
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practiceCharles D Blanke, Richard M Goldberg, Axel Grothey, et al.
Journal of the National Cancer Institute|December 14, 2018
Current Activities of the Coalition of Cancer Cooperative GroupsMonica M Bertagnolli, Susan M Blaney, Charles D Blanke, et al.
Pageof 16